Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Biosynthesis wikipedia , lookup
Butyric acid wikipedia , lookup
Basal metabolic rate wikipedia , lookup
Biochemistry wikipedia , lookup
Metalloprotein wikipedia , lookup
Citric acid cycle wikipedia , lookup
Microbial metabolism wikipedia , lookup
Glyceroneogenesis wikipedia , lookup
Evolution of metal ions in biological systems wikipedia , lookup
95 Bbchemistry of Ewrciw l3COZenrichment (from [ 1-13C]palmitate) and 14C0, specific activity (SA) (from [1-14C] acetate) were measured over the last 20 min to determine the recovery of label from acetate and to calculate plasma FFA oxidation rates. Acetate directly enters the TCA cycle and, under the present experimental conditions, is completely oxidized; thus, the label in acetate that is retained in the body will reflect label fixation via exchange reactions in the TCA cycle and also via labeled COz fixation by other mechanisms. Since at rest there is no net use of intracellular fatty acids, tracer estimates of plasma FFA oxidation should approximate total fatty acid oxidation, if the correction is valid. The fractional recovery of label from acetate was 0.5920.12 (mean+SE). Total fatty acid oxidation, calculated from indirect calorimetry (IC), was 3.35 +- 0.29 pmol. kg-'. m i d . Isotopically determined plasma FFA oxidation rates were 1.96 +0.16 (pc0.05 vs IC), and 3.34 2 0.24 pmol. kg-'. min-'@=NS vs IC) when 1.0 (i.e; no correction), or 0.59 (i.e; the "acetate correction") were used as correction factors, respectively. We have also performed experimentsduring exercise of moderate intensity to determine the effect of label fixation on estimations of plasma and intracellular fatty acid oxidation. [ 1-I3C] Palmitate and [ 1-'4C]acetate were infused intravenously in 5 healthy volunteers during 1 hour of cycling at 402 10% V0,max. The fractional recovery of label from acetate was 0.8620.03. Total fatty acid oxidation, calculated from indirect calorimetry, was 10.721.9 pmol. kg-'. m i d . Without correction, plasma FFA oxidation was 6.720.6pmol. kg". m i d , and intracellular fatty acid oxidation was 4.020.5 pmol. kg-'. m i d . When the "acetate correction factor" (i.e; 0.86) was applied, plasma FFA oxidation was 15% higher and intracellular fatty acid oxidation was 25% lower. We conclude that the "acetate correction factor" enables accurate determination of plasma FFA oxidation using tracer techniques, and failure to use this factor may result in a significant overestimation of the oxidation of intramuscular fatty acids during exercise. drugs, change substrate metabolism during exercise'. The effects of low and high doses of B, selective and non selective drugs on exercise metabolism were examined. 20 healthy subjects, male and female, walked on a treadmill at 50% of their VOz max for 1 hr, 5 times, on each treatment, in random order: Placebo Metoprolol(50 mg) (MP 50) Metoprolol(100 mg) (MP 100) Propranolol(40 mg) (Pr 40) Propranolol(80 mg) (Pr 80) Energy expenditure and fat oxidation were assessed by indirect calorimetry. Blood was drawn via an intravenous cannula, and plasma assayed for free fatty acids (FFA), glycerol, glucose, lactate and ammonia. All beta blockers reduced fat oxidation to some degree (Table). Decreased fat oxidation correlated with increased plasma ammonia (8 = .924, p = .009), and increased leg effort (8 = .964, p = .003). At 60 min of exercise, plasma ammonia was significantlyhigher than placebo on Pr 40, Pr 80 and Mp 100 (p = <.0001 for all). On Mp 50, there was no difference from placebo (p = .3274). Increased plasma ammonia correlated with increased leg effort (r2 = . 9 4 , p = .OW). Plasma free fatty acids were lower than placebo on all drug treatments (p = <.0001 ), but there were no differences between drugs. It is proposed that the additional inhibition of fat oxidation with a non selective drug occurs in intramuscular B, mediated lipolysis, rather than in adipose lipolysis, as blockade of adipose FFA release was maximal for all drug treatments. Supported by NIH- grants DK-34817.and DK-46017. Labros S. Sidossis was an "Alexander S. Onassis" Foundation Scholar. Propranold 4Omg 106*'* PmpnnokA 80mg FAT METABOLISM DURING ONE HOURS EXERCISE ON HIGH AND LOW DOSES O F PROPRANOLOL, METOPROLOL OR PLACEBO A Head, S Maxwell, MJ Kendall. C.I.U., Q.E. Hospital, Birmingham. 151 Beta-blockers, particularly non B, selective Table: Heart rate (HR), fat oxidation and plasma free fatty acids (FFA) during ihr treadmill exercise at 50% V O , (N=20) IFat FFA Treatment HR s.d. at Wmin s.d (pmoVl) Placcbo 11 42.7 11.6 300.5 10 38.79 14.1 117.8"' 7 36.3.. 13.7 152.88g' 169.6 8 31.2.V 9.3 134.1*** 114.4 8 29.5*'*## 10.9 111.0*** 84.0 134 s.d 217.4 Metropmld Mmg 103*** Mctmpmld 100mg 97*** 97*** 79.5 Significantly lower than placebo +p= <.05, **p= <.01, '**p= C.001 Significantly lower than metoprolol 'p= <.O1,"p= <.OO1. 1. Clerow J, Leenen FH: Effects of beta blockade on muscle metabolism during prolonged exercise. A short review.Am J Hypertension 19881; 290s-294s